Quadrant Capital Group’s BioTelemetry, Inc. BEAT Stock Holding History

Quadrant Capital Group’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-131	Closed	-$9K	–	2518
2020 Q4	$9K	Buy	131 +25	+24%	+$1.31K	﹤0.01%	1464
2020 Q3	$5K	Buy	+106	New	+$4.43K	﹤0.01%	1596

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Quadrant Capital Group's BEAT Position: Q1 2021 in Review

Quadrant Capital Group sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 131 shares — an estimated $9K sold.

Quadrant Capital Group first reported a position in BEAT in Q3 2020 and held it in 2 quarters. The position peaked at $9K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Quadrant Capital Group reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Quadrant Capital Group sold 131 BioTelemetry, Inc. shares in Q1 2021, an estimated $9K.
Quadrant Capital Group first reported a position in BioTelemetry, Inc. in Q3 2020 and held it in 2 quarters.
Quadrant Capital Group's BioTelemetry, Inc. position peaked at $9K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Quadrant Capital Group's 13F filing for Q1 2021, filed 12 May 2021.